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Making pathogen-based mastitis treatment protocols 
work for many dairies 
By Amy Vasques
Mild or moderate clinical 
mastitis is defined as 
infection or inflammation 
of the mammary gland that 
results in abnormalities in 
milk consistency or color 
and/or swelling or redness 
of the affected gland. These 
cases differ from severe 
mastitis, which manifests as 
a systemically sick cow. Cows 
with severe signs most often 
need systemic and supportive 
treatment. The financial impact 
of all cases of mastitis on U.S. 
dairies amounts to over $2 
billion annually, with losses 
attributed to treatment costs, 
milk loss, milk withholds and 
decreases in reproductive 
efficiency. Research indicates 
that these costs can be reduced 
without appreciable negative 
outcomes by selectively treating 
non-severe cases, rather 
than treating all cases with 
antibiotics.
Why does this work? 
Microbiological characterization 
of the behavior of mastitis 
pathogens as well as on-farm 
clinical trials indicate that 
groups of pathogens, namely 
Gram-negative bugs such as 
Pseudomonas, respond poorly 
to antibiotics. Alternatively, 
cows with pathogens such 
as E. coli experience high 
self-cure rates. Additionally, 
approximately 30 percent of 
cultures from mastitic cows 
return negative results. 
With this knowledge, many 
dairies use an evidence-based 
approach to drive mastitis 
treatment strategies. For 
example, implementation of 
a pathogen-based protocol 
could involve use of on-farm 
culture (OFC) to treat only cows 
with Gram-positive results. 
There are several challenges to 
making on-farm culturing work. 
It requires a detail-oriented, 
dedicated individual(s) not only 
to retrieve samples, inoculate 
the culture plates, and to read 
the results, but also to maintain 
inventory of supplies, keep 
adequate records, and ensure 
proper function of the incubator. 
On-farm culturing may entail 
frequent training for proficiency, 
Herd
Treatment 
Protocol
Compliance
BTSCC 
Before
BTSCC 
After
ME305 
Before
ME305
After
1 Gram + — 169,000 125,000 32,650 26,083
2 Gram + 85% 188,000 146,000 32,275 31,135
3
Gram +, Cull
S. aureus
96% 139,000 178,000 30,777 30,793
4 Gram + 94% 90,000 89,000 31,360 31,800
5
All but  
"No-Growth"
73% 109,000 116,000 28,694 28,915
6 Gram + 85% 208,000 195,000 27,744 27,744
Average 165,875 147,500 30,953 29,670
TABLE 1 
Treatment protocols, compliance, and bulk tank and milk production characteristics for 
moderate-sized New York dairy herds enrolled in a pathogen-based mastitis treatment protocol 
with 24-hour sample pickup five days per week to drive treatment decisions.
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and some organisms, such 
as Mycoplasma species and 
Prototheca, will not grow using 
traditional methods or may be 
difficult to detect.
To explore an alternative 
to on-farm culturing, our 
group used culture results 
generated by a veterinary 
diagnostic laboratory to drive 
pathogen-based treatment 
decisions on six New York dairy 
herds. Mastitis samples were 
submitted five days per week 
with results reported 24 to 
36 hours later. This simulated 
the weekday services offered 
by veterinary clinics that also 
have the capacity to culture 
during a typical workweek. 
Each enrolled herd milked 500 
to 1,000 cows and four of the 
six dairies treated all clinical 
cases. The two remaining 
herds practiced pathogen-
based therapy at the time of 
enrollment: one herd relied 
on once per week diagnostic 
lab submissions while the 
other used on-farm culturing 
with minimal guidance. All 
owners and managers were 
asked to work with their herd 
veterinarian to develop a 
protocol that worked for their 
dairy but were permitted to 
treat animals on days when 
samples were not submitted. 
FIGURE 1 
Distribution of mastitis pathogens from cows with non-severe mastitis on six New York dairy herds.
Herd 1 (n=150) Herd 2 (n=113) Herd 3 (n=153)
Herd 4 (n=154) Herd 5 (n=96) Herd 6 (n=53)
Negative
Staph. spp.
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E.coli
Strep. Dysgalactiae
Other Gram +
Klebsiella
Strep. uberis
Other
Other Gram –
Strep. spp.
Contamination
Staph. aureus.
Lactococcus
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Briefly, all dairies chose to 
treat non-contagious Gram-
positive pathogens with an 
intramammary antibiotic. All 
dairies chose not to treat any 
quarter with a negative culture 
result. Variation existed in 
regards to treatment of Gram-
negative pathogens (Table 1). 
A total of 719 cases of non-
severe mastitis were enrolled. 
Distribution of pathogens 
varied by herd (Figure 1) 
and was the main driver of 
antibiotic use (Figure 2). For 
example, Herd Six elected 
to treat only Gram-positive 
pathogens, which amounted 
to less than 10 percent of 
their cases. Differences in 
adopted protocol and pathogen 
distribution among the six 
herds resulted in a range of 
reductions in antimicrobial use 
(6.8 percent to 92.5 percent). 
Decreased antibiotic use 
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resulted in savings between 
$2,200 and $4,600 per dairy 
per year when the costs of 
cultures and antibiotics were 
accounted for. Other economic 
benefits that were realized by 
farms were decreases in milk 
withhold time, the ability to 
make quick culling decisions 
based on culture results, and 
the ability to target cows with 
specific types of infections for 
supportive care.
Compliance to the individual 
protocol was high and ranged 
from 73 to 96 percent. The 
least-compliant culture results 
were for Gram-negative 
pathogens. Many of these “non-
compliant” cases graduated 
in severity, and cows were 
subsequently treated with 
systemic therapy. Bulk tank 
somatic cell count and mature-
equivalent milk production were 
similar before and after the 
study for the six dairies (Table 1). 
Finally, our study found 
that good record keeping 
is imperative to successful 
pathogen-based protocol, 
particularly to monitor disease 
incidents and changes in 
chronicity. This includes:
1 Recording all disease 
episodes (including treated and 
non-treated cows)
2 Use of a single event for each 
case of mastitis (If multiple 
treatments or “escape therapy” 
are used, avoid putting an 
additional event into the 
computer.)
3 Consistency of event 
remarks, including quarter, 
culture result and treatment 
Implementation of prompt 
reporting of culture results 
by nearby laboratories can 
effectively drive pathogen-
based clinical mastitis 
treatment decisions on 
moderate sized dairies, 
resulting in decreased use of 
antimicrobials on all dairies 
involved. Cultures from all six 
farms provided data that was 
useful for decision making, 
whether for treatment or 
culling. No negative outcomes 
were noted when evaluating 
bulk tank somatic cell count 
or milk production. The use of 
a pathogen-based treatment 
protocol based on five-day per 
week results has the potential 
to decrease antimicrobial 
use, promote product 
sustainability and protect 
aspects of public health.  ❚
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FIGURE 2 
Percent of non-severe clinical mastitis cases treated with antimicrobials before and after 
implementation of a pathogen-based treatment protocol by herd. Herds used 24-hour sample 
pickup five days per week to drive treatment decisions. 
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